期刊文献+

耳后注射甲泼尼龙琥珀酸钠联合常规药物治疗重度突发性聋 被引量:16

Efficacy of combined postauricular methylprednisolone injection and systemic therapy for profound Idiopathic sudden hearing loss
下载PDF
导出
摘要 目的研究耳后注射甲泼尼龙琥珀酸钠(甲强龙)联合常规药物治疗重度突发性聋的临床效果及副反应,探讨耳后局部给药是否可取代传统全身激素给药方式。方法选取2014年6月-2015年5月就诊于首都医科大学附属北京安贞医院,符合研究条件的60例(61耳)突发性聋患者,均给予改善微循环及营养神经等常规治疗2周。患者随机分为两组:对照组(31耳)经静脉给予地塞米松磷酸钠注射液10 mg,每日1次,共5 d;耳后注射组(30耳)耳后注射甲强龙40 mg,每日1次,共5 d。采用SPSS 16.0软件进行统计学分析,比较治疗前后的疗效变化及副反应。结果给药后两周耳后注射组及对照组总有效率分别为76.67%和74.19%,显效率分别为36.67%,38.71%,差异无统计学意义。耳后注射组血压及血糖无明显变化。结论耳后注射甲强龙联合常规药物治疗突发性聋可获得满意疗效。耳后注射甲强龙有可能取代传统静脉激素给药用于突发性聋的治疗。 OBJECTIVE To investigate the efficacy and the related complications of combined postauricular methylprednisolone injection and systemic therapy for profound idiopathic sudden hearing loss(ISSNHL).METHODS Total of 60 patients with ISSNHLwho had received therapy from June 2014 to May 2015 in Beijing Anzhen Hospital affiliated to Capital University of Medical Science,were randomly divided into 2groups,the systemic application group(30 patients):dexamethasone(DEX) was applied intravenously in dose of 10 mg×5 d,and the postauricular injection group(30 patients):methylprednisolone sodium suecinate was injected subperiosteally near the upper one-thirds of postauricular sulcus every day,40 mg×5 d.All 60 patients received the same medications for 2 weeks to improve the hearing.Hearing and tympanic membrane were monitered before the injections and two weeks after the termination of injections.SPSS 16.0 software was used to analyze the data.RESULTS The postauricular injection group:23 of 30 ears had improvement of hearing.No related complications were reported.The systemic application group:23 of 31 ears had improvement of hearing(P〉0.05) No related complications were reported.CONCLUSION Combined postauricular methylprednisolone injection and systemic medications therapy can be considered as is an effective therapy for profound idiopathic sudden hearing loss.It can avoid the side-effects of high dose systemic corticostemid treatment.For ISSNHL patients,postauricular methylprednisolone injection may be an appropriate treatment.
出处 《中国耳鼻咽喉头颈外科》 CSCD 2016年第2期69-72,共4页 Chinese Archives of Otolaryngology-Head and Neck Surgery
关键词 听觉丧失 突发性 糖皮质激素类 临床方案 耳后注射 Hearig Loss Sudden Glucocorticoids Clinical Protocols postauricular injection
  • 相关文献

参考文献16

  • 1无.突发性聋的诊断和治疗指南(2005年,济南)[J].中华耳鼻咽喉头颈外科杂志,2006,41(5):325-325. 被引量:372
  • 2Stachler R J, Chandrasekhar SS, Archer SM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg, 2012, 146: S1-S35.
  • 3Mattox DE, Simmons FB. Natural history of sudden sensorineural heating loss. Ann Otol Rhinol Laryngol, 1977, 86: 463-480.
  • 4无,余力生,杨仕明,韩东一,郑虹,张榕,王海波,郑亿庆,任基浩,林鹏,王军,高志强,吴皓,韩德民,陈锡辉,殷善开,董明敏,张劲,柯星星,胡国华,赵晓埝,姜学钧,孙建军,许珉,邱建新,邱建华,孙敬武,王宁宇,刘月辉,郭玉芬,周慧芳,迟放鲁,孔维佳,黄魏宁,刘稳,潘滔.中国突发性聋分型治疗的多中心临床研究[J].中华耳鼻咽喉头颈外科杂志,2013,48(5):355-361. 被引量:281
  • 5Michel O, Deutsche Gesellschaft for Hals-Nasen-Ohren- Heilkunde, Kopf-und Hals-Chirurgie. The revised version of the german guidelines "sudden idiopathic sensorineural hearing loss". Laryngorhinootologie, 2011, 90: 290-293.
  • 6Mort DJ, Bronstein AM. Sudden deafness. Curr Opin Neurol, 2006, 19: 1-3.
  • 7Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol, 1980, 106: 772-776.
  • 8Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: II. A Meta-analysis. Arch Otolaryngol Head Neck Surg, 2007, 133: 582-586.
  • 9肖玉丽,张蕾,闫杰.地塞米松治疗突发性聋[J].中国耳鼻咽喉头颈外科,2006,13(2):85-87. 被引量:17
  • 10赵玉沛.胰腺癌诊断与治疗的现状与未来[J].中华肝胆外科杂志,2009,15(5):321-323. 被引量:44

二级参考文献88

  • 1杨仕明,郭维,杨伟炎,顾瑞.国内突发性聋临床诊治研究论文的再评价[J].中华耳科学杂志,2005,3(3):208-211. 被引量:18
  • 2杨伟炎,杨仕明.关于突发性聋诊断和疗效标准的讨论[J].中华耳鼻咽喉头颈外科杂志,2006,41(5):324-325. 被引量:33
  • 3突发性聋的诊断和治疗指南(2005年,济南)[J].中华耳鼻咽喉头颈外科杂志,2006,41(8):569-569. 被引量:852
  • 4余力生,夏瑞明,杨仕明.关于我国突发性聋临床多中心研究的设想[J].中国医学文摘(耳鼻咽喉科学),2007,22(2):100-101. 被引量:8
  • 5中华医学会耳鼻咽喉科学会 中华耳鼻咽喉科杂志编辑委员会.突发性聋诊断依据和疗效分级[J].中华耳鼻咽喉科杂志,1997,32:72-72.
  • 6Jemal A, Siegel R, Ward E, et al. Cancer Statistics 2008. CA Cancer J Clin, 2008,58:71-96.
  • 7Lochan R, Daly AK, Reeves HL, et al, Genetic susceptibility in pancreatic ductal adenoearcinoma. Bri J Surg, 2008,95 : 22-32.
  • 8Hassan MM, Bondy ML, Wolff RA, et al. Risk Factors for Pancreatic Cancer: Case-Control Study. Am J Gastroenterol, 2007, 102: 2696-2707.
  • 9Katz MH, Hwang R, Fleming JB, et al. Tumor-node-metastasis staging of pancreatic adenocarcinoma. CA Cancer J Clin, 2008,58:111-125.
  • 10Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg, 2007,246 : 52- 60.

共引文献725

同被引文献134

引证文献16

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部